Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease
Drugs targeting cardiovascular disease (CVD) can have negative consequences for liver function. Here, the authors combine genome wide analyses on 69,479 individuals to identify loss-of-function variants with beneficial effects on CVD-related traits without negative impacts on liver function.
Enregistré dans:
Documents similaires
-
Ten simple rules for conducting a mendelian randomization study.
par: Sarah A Gagliano Taliun, et autres
Publié: (2021) -
Climate and ecology in the Rocky Mountain interior after the early Eocene Climatic Optimum
par: R. A. Stein, et autres
Publié: (2021) -
A rapid phenotype change in the pathogen Perkinsus marinus was associated with a historically significant marine disease emergence in the eastern oyster
par: Ryan B. Carnegie, et autres
Publié: (2021) -
Wild type and vte4 mutant Arabidopsis thaliana responses to different water frequencies: genetic engineering towards stress tolerance
par: Khalatbari,A. A, et autres
Publié: (2015) -
Differential Alphavirus Defective RNA Diversity between Intracellular and Extracellular Compartments Is Driven by Subgenomic Recombination Events
par: R. M. Langsjoen, et autres
Publié: (2020)